The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
Metabolism
; 63(1): 112-9, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-24139096
Key words
1,2-dimyristoyl-sn-glycero-3-phosphocholin; 2-chloro-5-nitrobenzanilide; 3,3'-Diaminobenzidine; 4',6-diamidino-2-phenylindole; Atherosclerosis; CR; DAB; DAPI; DMPC; DMSO; DNase; Dyslipidemia; GW9662; Glut 4; H&E; HDL; HSPG; HUVEC; IPGTT; LDL; LPL; LRP1; MEM; PCR; PDE3; PPAR-γ; PPARγ; PPRE; Polymerase chain reaction; RNase; RT; RT-PCR; Reverse transcriptase; STZ; TG; VLDL; apoE; apolipoprotein E; chylomicron remnants; dNTP; deoxyriboNTP; deoxyribonuclease; dimethyl sulfoxide; glucose transporter 4; hematoxylin and eosin; heparan sulfate proteoglycans; high-density lipoprotein; human umbilical vein endothelia cell; i.p. glucose tolerance test; lipoprotein lipase; low-density lipoprotein; low-density lipoprotein receptor-related protein 1; minimum essential medium; peroxisome proliferator activated receptor-γ; peroxisome proliferator response element; phosphodiesterase 3; real-time polymerase chain reaction; ribonuclease; siRNA; small interfering RNA;PKA, protein kinase A; streptozotocin; triglyceride; very low-density lipoproteins
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tetrazoles
/
Triglycerides
/
Low Density Lipoprotein Receptor-Related Protein-1
/
Liver
/
Hypolipidemic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Metabolism
Year:
2014
Document type:
Article